What is the recommended treatment for shingles?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 30, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Shingles Treatment

The recommended treatment for shingles (herpes zoster) is oral antiviral therapy with valacyclovir 1 gram three times daily for 7 days, initiated within 72 hours of rash onset for maximum effectiveness. 1

Initial Assessment and Diagnosis

  • Shingles presents as a unilateral, dermatomal rash with vesicular lesions
  • Prodromal symptoms often precede the rash by 2-3 days, including:
    • Burning pain
    • Tingling
    • Itching
    • Abnormal skin sensations in the affected dermatome

Antiviral Therapy Options

First-line Treatment

  • Valacyclovir: 1 gram orally three times daily for 7 days 1, 2
    • Most convenient dosing schedule
    • Better bioavailability than acyclovir
    • Significantly faster alleviation of zoster-associated pain compared to acyclovir 3

Alternative Options

  • Famciclovir: 500 mg orally three times daily for 7 days 1, 4
  • Acyclovir: 800 mg orally five times daily for 7 days 5

Timing of Treatment

  • Initiate treatment at the earliest sign or symptom of herpes zoster 1, 4
  • Most effective when started within 72 hours of rash onset 5
  • However, treatment may still be beneficial when started after 72 hours, especially in patients with ongoing new vesicle formation or immunocompromised status 3

Special Considerations

Immunocompromised Patients

  • Antiviral therapy is strongly recommended for all immunocompromised patients 6
  • For severe cases or immunosuppressed patients:
    • Consider intravenous acyclovir 1
    • Immunosuppressive therapy should be discontinued in severe cases of varicella infection and disseminated VZV 6

Complicated Shingles

  • For complicated shingles (multi-dermatomal, ophthalmic, visceral, or disseminated):
    • Intravenous acyclovir is recommended 6
    • Ophthalmology consultation is required for ophthalmic involvement 1

Renal Impairment

  • Dose adjustment required for valacyclovir in patients with renal impairment:
    • For creatinine clearance 10-29 mL/min: 1 gram every 24 hours 1
    • For creatinine clearance <10 mL/min: 500 mg every 24 hours 1

Pain Management

  • Acute pain management:

    • NSAIDs or acetaminophen for mild pain
    • Consider opioid analgesics for moderate to severe pain
    • Addition of a neuroactive agent (e.g., amitriptyline) can be helpful 7
  • For postherpetic neuralgia (pain persisting >90 days after rash):

    • Tricyclic antidepressants (amitriptyline)
    • Anticonvulsants (gabapentin, pregabalin)
    • Topical agents (lidocaine patches, capsaicin) 8, 5

Monitoring and Follow-up

  • No laboratory monitoring is needed in patients with normal renal function 1
  • Treatment failure should be suspected if lesions do not begin to resolve within 7-10 days 1
  • Monitor for potential adverse effects:
    • Nausea, headache (common with valacyclovir) 1
    • Neurological symptoms (confusion, agitation, hallucinations) which may indicate neurotoxicity 1

Prevention

  • Varicella zoster virus vaccine is recommended for adults 60 years and older to decrease the incidence of herpes zoster 5
  • Vaccination is contraindicated in immunocompromised individuals 6

Clinical Pearls

  • Early treatment is crucial for reducing the risk of postherpetic neuralgia
  • The convenience of valacyclovir's three-times-daily dosing may improve adherence compared to acyclovir's five-times-daily regimen
  • Acyclovir-resistant HSV can be treated with foscarnet 40 mg/kg IV three times daily 1
  • Patients should be advised to avoid contact with individuals who have not had chickenpox or the varicella vaccine until lesions have crusted over

References

Guideline

Genital Herpes Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Herpes zoster guideline of the German Dermatology Society (DDG).

Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology, 2003

Research

Treatment of postherpetic neuralgia.

Skin therapy letter, 2004

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.